You are here: Industry Insights > GlobalData

News List

Remote patient monitoring to be most impactful trend in pharma industry in 2021 expresspharma
January 21, 2021
Ongoing COVID-19 lockdowns and requirements of social distancing have swiftly pushed healthcare provision and patient monitoring towards remote options.
$30 bn sales forecast for Pfizer-BioNTech COVID-19 vaccine from 2020-2026: GlobalData expresspharma
January 12, 2021
The main challenge for BNT-162b2 is the ultra-cold storage requirement of -80°C. The vaccine is likely to suffer poor uptake in countries that have limited cold-chain logistics.
Value of pharma’s M&A deals remain high, despite COVID-19 europeanpharmaceuticalreview
January 11, 2021
Analysts say M&A deals continue to be a core driver of pharma/biopharma industry growth and that 2021 will likely be another year of high deal value.
Drug pricing, reimbursement constraints leading impediments to industry growth in 2021: GlobalData expresspharma
January 11, 2021
In 2021, drug pricing pressure from regulators and payers will remain and aggressive negotiation tactics to drive down drug prices will continue, according to GlobalData, a data and analytics company.
COVID-19 vaccine key conversation driver for Pfizer among Twitter influencers during Q4 2020– GlobalData expresspharma
January 07, 2021
The Medicines & Healthcare Products Regulatory Agency (MHRA) in the UK and the US Food and Drug Administration (FDA) authorised Pfizer and BioNTech’s mRNA vaccine (BNT162b2) for emergency use against COVID-19 in December 2020.
M&As in bio/pharma industry high despite COVID-19: GlobalData expresspharma
December 28, 2020
Down only 13 per cent compared with last year, with a total deal value of $228 billion compared with $262 billion in 2020, and almost twice the 2017 total deal value of $126 billion.
49 per cent of clinical trial disruption due to slow enrollment- GlobalData expresspharma
December 22, 2020
The fastest rate of trial disruption was between early April and mid-May, and the number of trials disrupted by COVID-19 peaked in the first week of June
COVID-19 expedites India’s focus on innovation within pharma: GlobalData expresspharma
December 16, 2020
According to the Global Innovation Index, India has moved up four places to 48 in the overall ranking across sectors in 2020.
New therapies will overcome unmet needs in hepatocellular carcinoma: GlobalData expresspharma
December 14, 2020
They have different mechanisms of action and are aiming to meet needs in different treatment settings.
Aesthetic injectables market in APAC to reach $3.8 billion in 2030: GlobalData expresspharma
December 09, 2020
The growth is drive by an increasing number of aesthetic procedures, technological advancements, growing urban population, preference to non-surgical and minimally invasive procedures and better patient outcomes.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page